Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Drug Design, Development and Therapy|January 2, 2015
Designing biologic selectivity for inflammatory bowel disease--role of vedolizumabNiklas Krupka, Daniel C Baumgart
Therapeutic Advances in Gastroenterology|November 15, 2021
Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysisDaniel Segna, Nele Brusselaers, Damian Glaus, et al.
World Journal of Gastrointestinal Endoscopy|February 5, 2024
Propofol sedation in routine endoscopy: A case series comparing target controlled infusion vs manually controlled bolus conceptRiad Sarraj, Lorenz Theiler, Nima Vakilzadeh, et al.
British Journal of Pharmacology|November 4, 2020
The oxysterol receptor GPR183 in inflammatory bowel diseasesBenjamin Misselwitz, Annika Wyss, Tina Raselli, et al.
Gut Microbes|April 18, 2026
The duodenal microbiota is compartmentalized and clinically stable yet rapidly responsive to nutrient exposureJacqueline Wyss, Stefan Baehler, Jasmin Ferracini, et al.
Cell Host & Microbe|November 1, 2022
Plasticity of the adult human small intestinal stoma microbiotaBahtiyar Yilmaz, Tobias Fuhrer, Deborah Morgenthaler, et al.
Therapeutic Advances in Gastroenterology|September 6, 2021
Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysisAlexander R Siebenhüner, Jean-Benoît Rossel, Philipp Schreiner, et al.
Pageof 3